For type 2 diabetes mellitus patients, regardless of the presence or absence of cardiovascular disease, NT-proBNP may refine the risk prediction for death and cardiovascular events and improve the predictive powers of traditional risk models. This evidence concerns the gene NPPB and type 2 diabetes mellitus.